January 29, 2014
Eli Lilly and Co. Ltd. and other drugmakers sued Par Pharmaceutical Cos. Inc. on Friday in New Jersey federal court, alleging the company's proposed generic version of Effient, used to manage cardiovascular events in patients with acute coronary syndrome, infringes their patents.